ArticleMolecular therapy oncolytics2023

Exploiting frequent and specific expression of PRL3 in pediatric solid tumors for first-in-child use of PRL3-zumab humanized antibody.

Amos Hong Pheng Loh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.